Resources Available from the Multiple Sclerosis Association of America Amidst the COVID-19 Pandemic

Challenges presented by the COVID-19 pandemic can be even more stressful and overwhelming for people living with chronic illnesses. As a trusted resource for the multiple sclerosis (MS) community, the Multiple Sclerosis Association of America (MSAA) is committed to providing accurate, up-to-date information, and resources during this time. Webinars about COVID-19 and Multiple Sclerosis Streamed […]

Read News Article

Bafiertam Oral Capsules Approved by the FDA for Relapsing Forms of MS

On April 30, 2020, Banner Life Sciences LLC (Banner), a privately held specialty pharmaceutical company, announced the United States Food and Drug Administration (FDA) approval of Bafiertam™ (monomethyl fumarate) delayed-release oral capsules to treat relapsing forms of multiple sclerosis (MS). This approval includes the treatment of clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary-progressive MS (SPMS). Banner has not yet announced when the medication will be available to the MS community.

Read News Article

FDA Approves Zeposia® (ozanimod) for the Treatment of Relapsing Forms of MS

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD Overview On March 26, 2020, Bristol Myers Squibb announced that the United States Food and Drug Administration (FDA) approved Zeposia® (ozanimod) for the treatment of adults with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary-progressive MS […]

Read News Article

The Coronavirus and MS: What You Need to Know

The “coronavirus disease 2019” (COVID-19) is a potentially serious respiratory disease that was first reported in December 2019 in China. As of early March 2020, the illness had made its way to almost 70 locations, including the United States, and has affected more than 90,000 individuals worldwide. Please be aware that these figures are expected to increase on a weekly or even a daily basis.

Read News Article

Learn about the Mind, Body, and MS Connection During MSAA’s 2020 MS Awareness Month Campaign

The Multiple Sclerosis Association of America (MSAA) recognizes March as Multiple Sclerosis (MS) Awareness Month. For this year’s campaign, MSAA is focusing on The Mind, Body, and MS Connection, addressing the integration of physical and emotional wellness strategies to improve MS symptom management and overall quality of life. MSAA invites the MS community to participate […]

Read News Article

MSAA Recognizes 50 Years of Supporting the Multiple Sclerosis Community

The Multiple Sclerosis Association of America (MSAA), founded in 1970, is proud to recognize its 50th Anniversary in 2020 as a nonprofit organization dedicated to supporting the multiple sclerosis community and Improving Lives Today through vital services and support. MSAA would like to share several initiatives and events dedicated to commemorating this important milestone: To […]

Read News Article

What’s New in MS Research: January 2020

To live with multiple sclerosis (MS) is to cope with the challenges it presents and to look forward to the promise of ongoing progress in understanding and managing the condition. This edition of “What’s New in MS Research” reflects that mix of obstacles and opportunities.

Read News Article

MSAA Debuts New Logo and Website Design

The Multiple Sclerosis Association of America (MSAA) is pleased to introduce our new logo and redesigned website homepage! As we enter our 50th year of dedicated service to the MS community, we are proud to share this important announcement about our new brand identity. While we are excited about our new look, please be assured […]

Read News Article

MSAA Announces New Chairperson of Healthcare Advisory Council

The Multiple Sclerosis Association of America (MSAA) is proud to announce the new Chairperson of the Healthcare Advisory Council for the organization. Dr. Carrie Hersh, a multiple sclerosis specialist at the Cleveland Clinic Lou Ruvo Center for Brain Health – Las Vegas, has assumed the position. Dr. Hersh joined the faculty at the Cleveland Clinic […]

Read News Article

FDA Approves Generic Versions of Gilenya®

On December 5, 2019, the United States Food and Drug Administration (FDA) announced that they had approved the applications from three separate pharmaceutical companies for the first generic versions of Gilenya® (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients.

Read News Article